Market Insights Health Pharmacies OTC Products

Skin Treatment (Pharmacies) - China

China

Revenue in the Skin Treatment market is projected to reach €2.31bn in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.84%, resulting in a market volume of €2.53bn by 2029.
In global comparison, most revenue will be generated in the United States (€3,077.00m in 2024).
In relation to total population figures, per person revenues of €1.61 are generated in 2024.

Key regions: Germany, Europe, South Korea, France, China

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Skin Treatment (Pharmacies) market in China has been experiencing significant growth in recent years. Customer preferences have shifted towards natural and organic products, driving the demand for skincare treatments in pharmacies. Additionally, the rise in disposable income and increasing awareness of skincare have contributed to the growth of the market.

Customer preferences: Chinese consumers have become more conscious of the ingredients used in skincare products, leading to a preference for natural and organic options. This shift in preferences is driven by concerns about the potential harmful effects of synthetic chemicals found in traditional skincare treatments. As a result, pharmacies have started stocking a wider range of natural and organic skincare products to cater to this growing demand.

Trends in the market: One of the key trends in the Skin Treatment (Pharmacies) market in China is the increasing popularity of anti-aging treatments. With the aging population in China, there is a growing demand for products that can help reduce the signs of aging and improve skin elasticity. Pharmacies have responded to this trend by offering a variety of anti-aging skincare products, including serums, creams, and masks. Another trend in the market is the rising demand for skincare products with sun protection properties. Chinese consumers are becoming more aware of the damaging effects of sun exposure on the skin and are seeking products that can provide adequate protection. Pharmacies have capitalized on this trend by stocking a wide range of sunscreens and sun protection products.

Local special circumstances: China has a unique skincare culture, with a strong emphasis on achieving a fair and flawless complexion. This cultural preference has driven the demand for products that can lighten the skin tone and reduce the appearance of dark spots and blemishes. Pharmacies have introduced a range of whitening and brightening skincare products to cater to this specific need.

Underlying macroeconomic factors: The growth of the Skin Treatment (Pharmacies) market in China can be attributed to several macroeconomic factors. Firstly, the rise in disposable income has allowed consumers to spend more on skincare products. As Chinese consumers become more affluent, they are willing to invest in high-quality skincare treatments available in pharmacies. Secondly, the increasing urbanization in China has led to a higher concentration of pharmacies in urban areas. This accessibility has made it easier for consumers to purchase skincare products from pharmacies, contributing to the growth of the market. In conclusion, the Skin Treatment (Pharmacies) market in China is experiencing growth due to shifting customer preferences towards natural and organic products, increasing awareness of skincare, and the rise in disposable income. Pharmacies are responding to these trends by offering a wide range of skincare treatments, including anti-aging and sun protection products. Additionally, the unique skincare culture in China, with a focus on achieving a fair complexion, has influenced the market. The underlying macroeconomic factors, such as rising disposable income and urbanization, have also contributed to the growth of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.